Johnson & Johnson hopes to start human trials for a coronavirus vaccine in September, with the first batches ready for use in early 2021

In the wake of the novel coronavirus pandemic, health experts, scientists, and pharmaceutical companies are scurrying to develop vaccines and treatments for the highly infectious and deadly disease. Johnson & Johnson, one of the largest pharmaceutical companies in the world, announced on Monday that they are planning to begin human clinical trials of its Covid-19 vaccine by September, with hopes of having the first batches ready for use by early 2021.